Paediatric drug optimization for antibiotics

  19 April 2023

Paediatric drug optimization (PADO) exercises aim to identify key priority products and their preferred product characteristics for research and development. These have been successfully undertaken for HIV, hepatitis C and tuberculosis, demonstrating their potential and impact to accelerate access to optimal formulations in the context of fragmented, small markets for medicines for children.

To address the remaining research gaps that hinder availability of appropriate therapeutics for children with bacterial infections, WHO convened and facilitated a paediatric exercise for antibiotics to ensure that research and development efforts in this field target a priority list of medicines, ensuring that children with bacterial infections can also rapidly benefit from safe, effective and accessible treatment options

Further reading: WHO
Author(s): WHO
Healthy Patients   Kids and Carers  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

Register

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed